ETFMG Treatments, Testing and Advancements ETF GERM
19.16 USD 0.00 (+0.00%)
Sep 5, 2024, 3:53 PM EDT
19.16 Day range 19.28
16.32 52-week range 20.20
News
benzinga.com Mpox Variant Sparks Global Concern As Europe, China Ramp Up Screening Increased screening for deadly new version of mpox is seen in Europe and China. More imported cases are expected. New vaccines are being developed.
benzinga.com FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak.
globenewswire.com Amplify ETFs to Liquidate Three ETFs CHICAGO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs, a leading provider of exchange traded funds, today announced the scheduled liquidation of three ETFs (the “Funds”). The Funds scheduled for…
etftrends.com Finding Opportunity in Unloved Healthcare ETFs Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?
etftrends.com Amplify's Christian Magoon on Purchase of ETFMG's ETFs In June, the ETF industry learned that issuer ETF Managers Group would be selling its funds to Amplify ETFs. The transaction, once completed, will bring Amplify's total AUM to $8 billion invested…
etftrends.com This Week in ETFs: A Summer Slowdown The week ending Friday, July 21, has been busy for the ETF industry, though launches were muted. A total of seven funds rolled out, which suggests the market could be entering some kind of summer…
zacks.com Biotech ETFs in Focus on Covid Vaccines' Fall Rollout The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.
seekingalpha.com Can Health Care Stocks Outperform Again In 2023? How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
zacks.com Here's Why COVID-Themed ETFs May Come Back Under the Radar COVID-themed stocks and ETFs were winners in 2020 and some parts of 2021 due to a spike in global coronavirus cases. We may see the same trend again as new COVID variants are 'pretty troublesome.
etftrends.com Biotech ETFs Slip After Novavax Cuts 2022 Guidance Biotechnology sector-related exchange traded funds retreated with Novavax Inc. (NasdaqGS: NVAX), plunging after the vaccine developer cut its 2022 revenue guidance in half. On Tuesday, the iShares…
etftrends.com Moderna Q2 Earnings, Buyback Plans Lift Biotech ETFs Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue in…
zacks.com Pharma & Biotech ETFs at One-Month High: Here's Why Pharma and biotech ETFs are in great shape and are trading at a one-month high level.
etf.com Vir Jumps 20% On S&P SmallCap 600 News Currently, 66 ETFs are affected, but it will be added to even more funds soon.
etf.com China ETFs Drop On Audit Enforcement The first tranche of Chinese ADRs affected by a 2020 law has been released.
zacks.com Biotech ETFs That Outperformed Last Week Biotech ETFs was the biggest gainer last week.
zacks.com Healthcare Emerges as Best Sector of Last Week: 5 Top ETFs Wall Street was downbeat last week with all indexes in the red. Still, Healthcare sector emerged as a key winner last week.
zacks.com 5 Best Sector ETFs of November Though the broad markets ended the month in red, a few sector ETFs performed remarkably well.
zacks.com Bet On COVID-Themed ETFs as New Cases Rise Globally The remainder of 2021 is expected to continue reeling under the spurt in coronavirus cases. Thus, a COVID-themed ETF could be a wise choice.
seekingalpha.com GERM ETF: A New Player In The Infectious Disease Segment ETF Managers Trust - ETFMG Treatments Testing and Advancements ETF is a biotech focused ETF invested in treatments and therapies firms.
zacks.com 7 Best ETFs of the First Nine Months of 2021 We highlight seven ETFs from different segments that have outperformed and gained more than 40% in the first nine months of 2021.
zacks.com Play COVID-Themed ETFs as US Labor Day Sees Rise in New Cases The remainder of 2021 is expected to continue reeling under the spurt in coronavirus cases. Thus, a COVID-themed ETF could be a wise choice.
zacks.com Healthcare ETFs to Gain on $65-Billion Pandemic Protection Plan The Biden administration recently offered a $65 billion plan that U.S. officials say is aimed at combating the biological threats after the COVID-19 pandemic goes away.